PsiGAD | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

28 results for “PsiGAD”

Trials

View all 18 →

Validation of the SIGAM/VF Mobility Grade

70 participants · First posted Aug 9, 2016

BE Study of Gaster®D Tab 20mg (Manufacturer Changed)

32 participants · First posted Oct 11, 2019

Transdiagnostic Group Cognitive Behavioral Therapy (PsicAP-A) for Adolescents With Emotional Disorders

160 participants · First posted Feb 28, 2020

Drugs

sIgA immunotherapy

177LU-PSIG-2

viral uptake inhibitors (SIGA)

Organizations

SIGA Technologies

India

SIGA TECHNOLOGIES, INC.

United States

News

Incannex Healthcare Secures $60 Million Financing to Advance Clinical Programs

Incannex Healthcare Announces Positive Clinical Trial Results and Financial Updates

XTL Biopharmaceuticals Acquires Psyga Bio to Create Leading Psychedelic Therapeutics Platform Following Trump Executive Order

Page 1 of 3